Immunotherapy drug combo helps extend the lives of patients with metastatic melanoma

Combining two immune checkpoint inhibitors helps overcome resistance to prior PD-1 therapy, curb the growth of deadly skin cancer
T cells attacking cancer cells
Credit: iStockphoto